Asia Pacific Inhalable Drugs Market Size & Outlook
Related Markets
Asia Pacific inhalable drugs market highlights
- The Asia Pacific inhalable drugs market generated a revenue of USD 5,120.4 million in 2024.
- The market is expected to grow at a CAGR of 7% from 2025 to 2030.
- In terms of segment, dry powder formulation was the largest revenue generating product in 2024.
- Dry powder formulation is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 5,120.4 million |
| Market revenue in 2030 | USD 7,700.7 million |
| Growth rate | 7% (CAGR from 2025 to 2030) |
| Largest segment | Dry powder formulation |
| Fastest growing segment | Dry powder formulation |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Aerosol, Dry powder formulation, Spray |
| Key market players worldwide | AstraZeneca PLC, Sanofi SA, Philip Morris International Inc, Viatris Inc, GSK PLC, Boehringer Ingelheim, Cipla Ltd DR, Boehringer Ingelheim Pharma |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.5% of the global inhalable drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 7,700.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Inhalable Drugs Market Scope
Inhalable Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Boehringer Ingelheim Pharma | View profile | 10001+ | Dortmund, Nordrhein-Westfalen, Germany, Europe | https://www.boehringer-ingelheim.de/unternehmensprofil/unser-unternehmen/standort-dortmund |
| Philip Morris International Inc | View profile | 82700 | 677 Washington Boulevard, Suite 1100, Stamford, New York, NY, United States, 06901 | https://www.pmi.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
Asia Pacific inhalable drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inhalable drugs market will help companies and investors design strategic landscapes.
Dry powder formulation was the largest segment with a revenue share of 44.7% in 2024. Horizon Databook has segmented the Asia Pacific inhalable drugs market based on aerosol, dry powder formulation, spray covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Asia Pacific inhalable drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific inhalable drugs market databook
-
Our clientele includes a mix of inhalable drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific inhalable drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific inhalable drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific inhalable drugs market size, by country, 2018-2030 (US$M)
Asia Pacific Inhalable Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
